Rede D'Or São Luiz S.A.
RDOR3
Peringkat dalam Saham
#1245
Rede D'Or São Luiz S.A. manages an extensive healthcare network across Brazil.... Rede D'Or São Luiz S.A. manages an extensive healthcare network across Brazil. The company delivers a comprehensive range of medical services, covering areas such as neurology, oncology, and pathology, alongside specialized treatments for hemangioma, lymphangioma, lymphatic malformation, and various vascular anomalies and tumors. Its offerings also include advanced vascular surgery, radiology, and interventional radiology. For younger patients, it provides expert care in pediatric cardiology, oncology, hematology, and surgery. This extensive enterprise comprises 51 wholly-owned hospitals, one managed hospital, and 47 oncology clinics, housing a total of 9,000 beds. Complementary services like blood banks, dialysis centers, and diverse specialized outpatient clinics are also part of its portfolio. Notably, Rede D'Or is equipped with robot surgery facilities across Brazil. Its geographical footprint extends to the states of Rio de Janeiro, São Paulo, Pernambuco, Bahia, Maranhão, Sergipe, Ceará, Paraná, and the Federal District. Founded in 1977, with its headquarters in São Paulo, Brazil, the company was previously known as Hospital Maternidade São Luiz S.A.
Harga Saham
$8.35
Terakhir disinkronkan: 2026-10-19
Kapitalisasi Pasar
$18.21B
Perubahan (1 hari)
2.30%
Perubahan (1 tahun)
9.30%
Negara
BR
Perdagangan Rede D'Or São Luiz S.A. (RDOR3)
Kategori
Healthcare
Laba untuk Rede D'Or São Luiz S.A. (RDOR3)
Laba pada Jun 2026 TTM: $1.25B
Menurut laporan keuangan terbaru dari Rede D'Or São Luiz S.A., laba saat ini perusahaan adalah $1.25B. Pada tahun 2023, perusahaan memperoleh laba sebesar $525.57M, peningkatan dibandingkan laba tahun 2022 sebesar $250.68M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Rede D'Or São Luiz S.A. dari 2013 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $1.25B | 57.29% |
| 2024 | $792.64M | 50.81% |
| 2023 | $525.57M | 109.66% |
| 2022 | $250.68M | -31.29% |
| 2021 | $364.84M | 291.93% |
| 2020 | $93.09M | -77.97% |
| 2019 | $422.63M | -0.30% |
| 2018 | $423.90M | -0.15% |
| 2017 | $424.56M | 26.06% |
| 2016 | $336.78M | 37.20% |
| 2015 | $245.47M | 66.19% |
| 2014 | $147.70M | 21.79% |
| 2013 | $121.27M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $9.87B | 691.76% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 210.01% |
US
|
|
| $687.82M | -44.83% |
SA
|
|
| - | - |
MY
|
